H. Gallant

Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.

D. Trepanier, R. Yatscoff, H. Gallant, 1998, Clinical biochemistry.

The Portal Immunosuppressive Storm: Relevance to Islet Transplantation?

A. Shapiro, J. Lakey, A. M. Shapiro, 2005, Therapeutic drug monitoring.

Portal vein immunosuppressant levels and islet graft toxicity.

A. M. Shapiro, N. Kneteman, R. Rajotte, 1998, Transplantation proceedings.

P70 S6 kinase assay: a pharmacodynamic monitoring strategy for rapamycin; assay development.

R. Yatscoff, H. Gallant, 1996, Transplantation proceedings.

Comparison of binding characteristics of four rapamycin metabolites to the 14 and 52 kDa immunophilins with their pharmacologic activity measured by the mixed-lymphocyte culture assay.

S. Soldin, R. Yatscoff, H. Gallant, 1996, Clinical biochemistry.